During the reporting period, its primary entity Tata 1mg Technologies reported revenue of Rs 375 crore with a threefold jump in profit after tax to Rs 65 crore. Meanwhile, subsidiary Tata 1mg Healthcare reported Rs 2,016 crore in turnover, reflecting 17% growth in its topline from FY24. It, however, suffered a net loss of Rs 342 crore. Tata Digital had acquired a strategic stake in 1mg in 2021. Since then, the company has raised just $40 million, through a rights issue from Tata Digital in 2022.